An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief ...

Reforming patent litigation to mirror successful outcomes across Europe could significantly accelerate US biosimilar market ...

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...

The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...

Stocks like GTPL Hathway, Adani Total Gas, Polyplex Corporation, SRF, Equitas Small Finance Bank, Samvardhana Motherson ...

With its dwindling cash reserves set to run out this month, Windtree Therapeutics had looked like it was struggling to hold ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

Increasing complexity, evolving consumer expectations, and tightened development timelines means that physical product ...

Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...

It also seeks to strengthen universal peace in larger freedom, We recognize that eradicating poverty in all its forms and dimensions, including extreme poverty, is the greatest global challenge and an ...